Nilsson Emma, Lichtenstein Paul, Cnattingius Sven, Murray Robin M, Hultman Christina M
Department of Medical Epidemiology, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Schizophr Res. 2002 Dec 1;58(2-3):221-9. doi: 10.1016/s0920-9964(01)00370-x.
Schizophrenia in the mother may imply an increased risk of adverse pregnancy outcome. However, inconclusive findings, unknown pathological mechanisms and possible confounding by social factors and smoking requests further explorations. The aim of this study were to (1) examine non-optimal pregnancy outcome using data from a population-based cohort, controlling for covariates known to influence fetal growth; and (2) perform separate analyses of women diagnosed before childbirth and women hospitalized for schizophrenia during pregnancy. The study sample comprised 2096 births by 1438 mothers diagnosed with schizophrenia (of whom 696 mothers were antenatal diagnosed and 188 admitted during pregnancy) and 1,555,975 births in the general population. We found significantly increased risks for stillbirth, infant death, preterm delivery, low birth weight, and small-for-gestational-age among the offspring of women with schizophrenia. Women with an episode of schizophrenia during pregnancy had the highest risks (e.g., low birth weight; OR 4.3, 95% CI 2.9-6.6 and stillbirth; OR 4.4, 95% CI 1.4-13.8). Controlling for a high incidence of smoking during pregnancy among schizophrenic women (51% vs. 24% in the normal population) and other maternal factors (single motherhood, maternal age, parity, maternal education, mothers' country of birth and pregnancy-induced hypertensive diseases) in a multiple regression model, reduced the risk estimates markedly. However, the risks for adverse pregnancy outcomes were even after adjustments generally doubled for women with an episode of schizophrenia during pregnancy compared to women in the control group (e.g., low birth weight; OR 2.3, 95% CI 1.5-3.5, preterm delivery; OR 2.4, 95% CI 1.5-3.8 and stillbirth; OR 2.5, 95% CI 0.8-7.9). The risks for preterm delivery and low birth weight were significantly elevated throughout the analyses. We conclude that schizophrenia in the mother implies an increased risk for poor perinatal outcome, not fully explained by maternal factors, and a need to consider a common familial (probably genetic) vulnerability for pre- and perinatal stress and schizophrenia.
母亲患有精神分裂症可能意味着不良妊娠结局的风险增加。然而,研究结果尚无定论,病理机制不明,且可能受到社会因素和吸烟的混杂影响,因此需要进一步探索。本研究的目的是:(1)利用基于人群队列的数据,在控制已知影响胎儿生长的协变量的情况下,研究非最佳妊娠结局;(2)对分娩前被诊断出精神分裂症的女性和孕期因精神分裂症住院的女性进行单独分析。研究样本包括1438名被诊断为精神分裂症的母亲所生的2096例新生儿(其中696名母亲在产前被诊断出,188名在孕期入院),以及普通人群中的1555975例新生儿。我们发现,精神分裂症女性后代出现死产、婴儿死亡、早产、低出生体重和小于胎龄儿的风险显著增加。孕期有精神分裂症发作的女性风险最高(例如,低出生体重;比值比4.3,95%置信区间2.9 - 6.6;死产;比值比4.4,95%置信区间1.4 - 13.8)。在多元回归模型中,控制精神分裂症女性孕期吸烟的高发生率(51%,而正常人群为24%)以及其他母亲因素(单身母亲身份、母亲年龄、产次、母亲教育程度、母亲出生国家和妊娠期高血压疾病)后,风险估计值显著降低。然而,与对照组女性相比,孕期有精神分裂症发作的女性不良妊娠结局的风险在调整后通常仍会翻倍(例如,低出生体重;比值比2.3,95%置信区间1.5 - 3.5;早产;比值比2.4,95%置信区间1.5 - 3.8;死产;比值比2.5,95%置信区间0.8 - 7.9)。在整个分析过程中,早产和低出生体重的风险显著升高。我们得出结论,母亲患有精神分裂症意味着围产期结局不良的风险增加,这不能完全由母亲因素解释,并且需要考虑产前和围产期应激与精神分裂症存在共同的家族性(可能是遗传性)易感性。